Anticancer Research

Journal info (provided by editor)

Issues per year
12
Articles published last year
848
Manuscripts received last year
2384
% accepted last year
36
% immediately rejected last year
2
Open access status
optional
Manuscript handling fee?
yes
Fee per page
$0
Kind of complaint procedure
Editorial board
Two-year impact factor
1.99
Disciplines: Oncology

Aims and Scope

ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed.
ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies).
Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the

SciRev ratings (provided by authors) (based on 1 review)

Duration of manuscript handling phases
Duration first review round 0.5 mnths compare →
Total handling time accepted manuscripts 0.5 mnths compare →
Decision time immediate rejection n/a compare →
Characteristics of peer review process
Average number of review reports 1.0 compare →
Average number of review rounds 1.0 compare →
Quality of review reports 5.0 compare →
Difficulty of reviewer comments n/a compare →
Overall rating manuscript handling 5.0 (range 0-5) compare →

Latest review

First review round: 2.3 weeks. Overall rating: 5 (excellent). Outcome: Accepted.